We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+3.86%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$18.8B
AUM Growth
+$1.08B
Cap. Flow
+$375M
Cap. Flow %
1.99%
Top 10 Hldgs %
32.3%
Holding
1,384
New
65
Increased
662
Reduced
357
Closed
63

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$243M
2
PLD icon
Prologis
PLD
+$106M
3
DLR icon
Digital Realty Trust
DLR
+$97.4M
4
KIM icon
Kimco Realty
KIM
+$96.3M
5
SNOW icon
Snowflake
SNOW
+$88.7M

Top Sells

Rank Stock Value
1
O icon
Realty Income
O
+$225M
2
INVH icon
Invitation Homes
INVH
+$153M
3
EQIX icon
Equinix
EQIX
+$91.3M
4
SPG icon
Simon Property Group
SPG
+$91.1M
5
AMT icon
American Tower
AMT
+$91M

Sector Composition

Rank Sector Weight
1 Real Estate 42.05%
2 Technology 19.13%
3 Communication Services 6.55%
4 Consumer Discretionary 6.17%
5 Financials 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABCL icon
1201
AbCellera Biologics
ABCL
$1.6B
$3K ﹤0.01%
1,151
AMCX icon
1202
PUT
AMC Global Media
AMCX
$445M
$3K ﹤0.01%
+600
New +$7.91K
ANAB icon
1203
AnaptysBio
ANAB
$1.59B
$3K ﹤0.01%
105
AUPH icon
1204
Aurinia Pharmaceuticals
AUPH
$1.96B
$3K ﹤0.01%
528
ETNB
1205
DELISTED
89bio
ETNB
$3K ﹤0.01%
344
GMAB icon
1206
Genmab
GMAB
$17.7B
$3K ﹤0.01%
102
-70
-41% -$1.99K
GRFS
1207
Grifois
GRFS
$5.27B
$3K ﹤0.01%
398
IEUR icon
1208
iShares Core MSCI Europe ETF
IEUR
$8.8B
$3K ﹤0.01%
+55
New +$3.19K
INVA icon
1209
Innoviva
INVA
$1.57B
$3K ﹤0.01%
160
-100
-38% -$1.55K
IRON icon
1210
Disc Medicine
IRON
$2.85B
$3K ﹤0.01%
59
-40
-40% -$1.36K
KNSA icon
1211
Kiniksa Pharmaceuticals
KNSA
$4.89B
$3K ﹤0.01%
139
NRIX icon
1212
Nurix Therapeutics
NRIX
$2.43B
$3K ﹤0.01%
152
OCUL icon
1213
Ocular Therapeutix
OCUL
$1.89B
$3K ﹤0.01%
407
RLAY icon
1214
Relay Therapeutics
RLAY
$4.06B
$3K ﹤0.01%
486
SAGE
1215
DELISTED
Sage Therapeutics
SAGE
$3K ﹤0.01%
239
SPRY icon
1216
ARS Pharmaceuticals
SPRY
$572M
$3K ﹤0.01%
367
TARS icon
1217
Tarsus Pharmaceuticals
TARS
$2.62B
$3K ﹤0.01%
107
TNGX icon
1218
Tango Therapeutics
TNGX
$4.35B
$3K ﹤0.01%
355
XLV icon
1219
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
$3K ﹤0.01%
+22
New +$3.16K
ZLAB icon
1220
Zai Lab
ZLAB
$2.1B
$3K ﹤0.01%
193
ADPT icon
1221
Adaptive Biotechnologies
ADPT
$3.61B
$2K ﹤0.01%
530
ARCT icon
1222
Arcturus Therapeutics
ARCT
$164M
$2K ﹤0.01%
90
BCYC
1223
Bicycle Therapeutics
BCYC
$276M
$2K ﹤0.01%
103
BNS icon
1224
Scotiabank
BNS
$106B
$2K ﹤0.01%
50
CNTA
1225
DELISTED
Centessa Pharmaceuticals
CNTA
$2K ﹤0.01%
211

Similar funds

Daiwa Securities Group's Q2 2024 Portfolio in Review

As of Q2 2024, Daiwa Securities Group held 1,384 positions worth $18.8B, up 6.1% from $17.7B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group's Q2 2024 filing shows 65 new, 662 increased, 357 reduced and 63 closed positions. Its largest new stake was NextEra Energy 7.299% Corporate Units: 500,000 shares worth $24.6M. The largest sale was Realty Income, an estimated $225M.

By sector, the portfolio is most concentrated in Real Estate at 42% of assets, down from 46% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 500,000 shares worth $24.6M.
  • Daiwa Securities Group added most to Crown Castle in Q2 2024, an estimated $243M increase.
  • Daiwa Securities Group's biggest Q2 2024 reduction was Realty Income, cutting an estimated $225M.
  • Daiwa Securities Group fully exited Apartment Income REIT Corp. in Q2 2024, selling an estimated $88.4M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $18.8B portfolio in Q2 2024.
  • Daiwa Securities Group opened 65 new positions and closed 63 in Q2 2024.
  • Daiwa Securities Group's portfolio value rose 6.1% quarter-over-quarter to $18.8B.

Based on Daiwa Securities Group's 13F filing for Q2 2024, filed 7 Aug 2024.